Skip to main content

Day: November 13, 2023

Atlantic American Corporation Reports Third Quarter Results for 2023

ATLANTA, Nov. 13, 2023 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net income of $1.8 million, or $0.08 per diluted share, for the three month period ended September 30, 2023, compared to net loss of $0.7 million, or $(0.04) per diluted share, for the three month period ended September 30, 2022. The Company had net income of $2.1 million, or $0.09 per diluted share, for the nine month period ended September 30, 2023, compared to net income of $0.5 million, or $0.01 per diluted share, for the nine month period ended September 30, 2022. The increase in net income for the three and nine month periods ended September 30, 2023 was primarily the result of a more favorable loss experience in the life and health operations, from the comparable periods in 2022, coupled with a decrease in unrealized losses...

Continue reading

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30, 2023. Jason Matuszewski, Chief Executive Officer of BioStem Technologies Inc. said, “2023 has been a remarkable year of growth and milestones for our organization, we are excited to share our latest achievements, innovations, and strategic partnerships that continue to drive our mission of advancing the development, manufacture, and commercialization of cutting-edge placental-derived allografts for advanced wound care. In this earnings call, we will delve...

Continue reading

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

IND enabling development activities for SCY-247, the next generation fungerp from SCYNEXIS’ proprietary antifungal platform, continue to advance Remediation strategies following the voluntary recall of BREXAFEMME® and the MARIO study clinical hold are being evaluated With cash, cash equivalents and investments of $105.2 million as of September 30, 2023, SCYNEXIS projects a cash runway of more than two yearsJERSEY CITY, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the third quarter ended September 30, 2023. “We faced unexpected challenges associated with the recent BREXAFEMME® recall and the clinical hold placed on the MARIO trial this quarter,”...

Continue reading

Star Bulk Carriers Corp. Reports Net Profit of $43.7 Million for the Third Quarter of 2023, and Declares Quarterly Dividend of $0.22 Per Share

ATHENS, Greece, Nov. 13, 2023 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk cargoes, today announced its unaudited financial and operating results for the third quarter of 2023. Unless otherwise indicated or unless the context requires otherwise, all references in this press release to “we,” “us,” “our,” or similar references, mean Star Bulk Carriers Corp. and, where applicable, its consolidated subsidiaries. Financial Highlights(Expressed in thousands of U.S. dollars, except for daily rates and per share data)        Third quarter 2023 Third quarter 2022 Nine months ended September 30, 2023 Nine months ended September 30, 2022Voyage Revenues $223,087 $364,136 $685,808 $1,142,353Net...

Continue reading

ECN Capital Reports US$0.00 in Adjusted Net Income per Common Share in Q3-2023

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial results for the three-month period ended September 30, 2023. For the three-month period ended September 30, 2023, ECN Capital reported Adjusted net income applicable to common shareholders from continuing operations of $0.5 million or $0.00 per share (basic) versus $0.7 million or $0.00 per share (basic) for the previous three-month period and $11.8 million or $0.05 per share (basic) for the same period last year. “Skyline’s strategic investment in ECN closed in the quarter and we began developing the new products and services needed to launch the Champion Financing JV in early 2024.”, said Steven Hudson, CEO of ECN Capital Corp. “Separately, the corporate simplification plan announced last quarter is...

Continue reading

First Watch Announces Acquisition of Six Franchise Restaurants in Florida

BRADENTON, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept, announced that it has acquired, effective today, six of its previously franchise-owned restaurants in Florida. “We’re thrilled to welcome our newest teams in the Florida Panhandle to the First Watch company-owned system. These franchise partners have served the community from Destin to Tallahassee for more than a decade, and we are thankful for their dedication and help in a successful transition,” said Chris Tomasso, First Watch CEO and President. “As part of our long-term growth strategy, we’ve now welcomed 23 new restaurants this year alone into the First Watch fold that were previously owned by our franchise partners. We look forward to celebrating our newest...

Continue reading

Mattr Announces Third Quarter 2023 Results

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — Shawcor Ltd., dba Mattr Infratech (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three and nine months ended September 30, 2023. This press release should be read in conjunction with the Company’s Management Discussion and Analysis (“MD&A”) and interim consolidated financial statements for the three and nine months ended September 30, 2023, which are available on the Company’s website and at www.sedarplus.com. Highlights from the third quarter include1:The Company entered into a definitive agreement to sell a substantial part of its Pipeline Performance Group (“PPG”) business which was previously reported under the Pipeline and Pipe Services (“PPS”) segment for $166 million USD, or approximately $230 million CAD at October 31,...

Continue reading

Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Biologics License Application for cosibelimab under review by U.S. FDA; PDUFA goal date of January 3, 2024 Recent publication of cosibelimab pivotal trial results in the Journal for ImmunoTherapy of Cancer WALTHAM, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the third quarter ended September 30, 2023, and recent corporate highlights. “The January 3, 2024, action date for our Biologics License Application (“BLA”) for cosibelimab is fast-approaching, and we continue to work closely with the U.S. Food and Drug Administration (“FDA”) in completing their review,” said James Oliviero, President and Chief Executive Officer of Checkpoint. “During the third quarter, pivotal trial results...

Continue reading

Hesai Group Reports Third Quarter 2023 Unaudited Financial Results

Quarterly net revenues were RMB445.6 million (US$61.1 million),1 an increase of 33.5% year-over-yearQuarterly lidar shipments were 47,4402 units, an increase of 125.5% year-over-year SHANGHAI, China, Nov. 13, 2023 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”), (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced its unaudited financial results for the three months ended September 30, 2023. Operational Highlights  Three months endedSeptember 30, 2023   Nine months endedSeptember 30, 2023ADAS lidar shipments 40,593   114,482Autonomous Mobility lidar shipments 6,847   19,898Total lidar shipments 47,440   134,380Q3 2023 ADAS lidar shipments were 40,593 units, compared to 16,694 units in the corresponding period of 2022. Q3 2023 Total lidar...

Continue reading

Northview Residential REIT Announces Q3 2023 Financial Results, Including Successful Completion of the Recapitalization Event, Continued Strong Same Door Performance, and Improved FFO Payout Ratio

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Nov. 13, 2023 (GLOBE NEWSWIRE) — Northview Residential REIT (“Northview” or the “REIT”, formerly Northview Fund) (NRR.UN – TSX), today announced financial results for the three and nine months ended September 30, 2023. All amounts in this news release are in thousands of Canadian dollars unless otherwise indicated. In August 2023, Northview’s units were consolidated on a 1.75 to 1.00 basis. All references to the number of units and per unit amounts in this news release have been restated and are reflected on a post-consolidation basis.“We were pleased that occupancy and AMR continued to improve through the third quarter of 2023, emphasizing the strong fundamentals of the multi-residential real estate market. Northview’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.